SCHEMBL27594916

SCHEMBL27594916

Oc1cc(Cl)c2c(ccc3c4ccc5ccccc5c4ccc32)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPRT1 P00492 3/20 0.50
▸ CYP1A2 P05177 5/20 0.47
▸ FYN P06241 2/20 0.47
▸ ACHE P22303 2/20 0.47
▸ AHR P35869 2/20 0.47
▸ ERBB2 P04626 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ NQO2 P16083 1/20 0.46
▸ MAPT P10636 3/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ APEX1 P27695 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ PMP22 Q01453 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ CYP2A6 P11509 3/20 0.43
▸ TSHR P16473 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ PAX8 Q06710 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27278968 0.84 CYP1A2 (0.48) HPRT1CYP1A2FYNACHEAHR
SCHEMBL27407869 0.84 HPRT1 (0.52) HPRT1CYP1A2NQO2MAPTLMNA
Methane SCHEMBL27684938 0.82 HPRT1 (0.50) HPRT1CYP1A2NQO2MAPTLMNA
SCHEMBL27456883 0.80 HPRT1 (0.44) HPRT1CYP1A2FYNACHEAHR
SCHEMBL3345624 0.79 CYP1A2 (0.74) HPRT1CYP1A2FYNACHEAHR
SCHEMBL27264740 0.79 ALDH1A1 (0.48) HPRT1CYP1A2FYNACHEAHR
SCHEMBL17841962 0.77 CYP1A2 (0.60) HPRT1CYP1A2FYNACHEAHR
SCHEMBL2849271 0.77 CYP1A2 (0.60) HPRT1CYP1A2FYNACHEAHR
SCHEMBL27289927 0.77 HPRT1 (0.64) HPRT1CYP1A2FYNACHEAHR
SCHEMBL12473664 0.77 HPRT1 (0.64) HPRT1CYP1A2FYNACHEAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102548984-B The inhibitor of PI3 kinases and/or MTOR AMGEN INC. (US) 2015-11-25 — — CN disclosed
CN-102105473-B Tricyclic nitrogen containing compounds and their use as antibacterials GLAXO GROUP LTD 2013-05-08 — — CN disclosed
CN-102892755-A Therapeutic compounds UNIV WAYNE STATE 2013-01-23 — — CN disclosed
CN-102548984-A Inhibitors of PI3 kinase and / or MTOR AMGEN INC 2012-07-04 — — CN disclosed
CN-101628888-B Inhibitors of cytosolic phospholipase a2 WYETH CORP 2012-05-23 — — CN disclosed
CN-102105473-A Tricyclic nitrogen containing compounds and their use as antibacterials GLAXO GROUP LTD 2011-06-22 — — CN disclosed
CN-101842357-A Substituted pyrazole derivatives TAKEDA PHARMACEUTICAL 2010-09-22 — — CN disclosed
CN-1863779-B indazole derivatives UBE INDUSTRIES 2010-05-05 — — CN disclosed
CN-101628888-A Inhibitors of cytosolic phospholipase A2 WYETH CORP 2010-01-20 — — CN disclosed
CN-100503566-C Cytosolic phospholipase A2 inhibitors WYETH CORP (US) 2009-06-24 — — CN disclosed
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 — — CN disclosed
CN-1863779-A Novel indazole derivative UBE INDUSTRIES (JP) 2006-11-15 — — CN disclosed
CN-1617855-A Cytosolic phospholipase A2Inhibitors WYETH CORP (US) 2005-05-18 — — CN disclosed
Send feedback